Work

Abstract 2943: SWY2321, a novel topoisomerase I inhibitor linked bispecific ADC targeting EGFR/cMet, exhibits potent anti-tumor efficacy

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2943

Authors: Jinyu Yang, Jing Qiao, Mo Dan, Xiwu Hui, Bing Yao, Can Yuan, Miaomiao Wei, Xiao Li, Xuening Lv

Institution: CSPC Pharmaceutical Group

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409626017

Cites:

Cited by:

Related to: 10